Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biostage Inc (BSTG)  
$2.46 0.02 (0.82%) as of 4:30 Fri 5/3


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 9,390,000
Market Cap: 23.10(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $2.18 - $6.13
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Biostage is a biotechnology company developing bioengineered organ implants based on its Cellframe™ and and Cellspan™ technology. Co.'s technology is comprised of a biocompatible scaffold, which is the foundation of its Cellframe™ technology, that is seeded with the patient's own mesenchymal stromal cells to form its Cellspan™ implant. Co.'s platform technology is being developed to treat life-threatening conditions of the esophagus, bronchus and trachea. Products being developed based on its technology for those indications are called Cellspan™ products. Co.'s primary research and development activities are focused in three areas: materials science, cell biology and engineering.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 5,100 24,864 175,878
Total Buy Value $0 $24,885 $113,394 $1,012,397
Total People Bought 0 1 2 4
Total Buy Transactions 0 3 7 11
Total Shares Sold 0 0 0 134,295
Total Sell Value $0 $0 $0 $962,849
Total People Sold 0 0 0 4
Total Sell Transactions 0 0 0 4
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 100
  Page 3 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Dst Capital Llc 10% Owner   –       –       •   2018-01-17 4 B $2.20 $11,000 I/I 5,000 10,450 1.5     -
   Dst Capital Llc 10% Owner   –       –       •   2018-01-12 4 B $2.16 $10,800 I/I 5,000 5,450 1.5     -
   Dst Capital Llc 10% Owner   –       –       •   2018-01-11 4 B $1.90 $380 I/I 200 450 1.42     -
   La Francesca Saverio President and CMO   •       •      –    2017-08-24 4 B $0.37 $37,000 D/D 100,000 293,998 2.81     -
   La Francesca Saverio President and CMO   •       •      –    2017-08-23 4 B $0.32 $48,000 D/D 150,000 193,998 2.81     -
   Dersimonian Harout Chief Scientific Officer   •       –      –    2016-10-12 4 B $0.91 $9,100 D/D 10,000 10,000 2.74     -
   Kennedy John F Director   –       •      –    2016-08-26 4 B $0.93 $15,033 D/D 16,182 58,406 2.39     -
   Mcgorry James Joseph President and CEO   •       •      –    2016-08-25 4 B $0.96 $24,000 D/D 25,000 126,300 2.81     -
   Mcgorry James Joseph President and CEO   •       •      –    2016-06-21 4 B $1.07 $21,400 D/D 20,000 101,300 2.81     -
   Robinson Thomas H Director   –       •      –    2016-06-13 4 B $1.17 $37,475 D/D 32,000 50,000 2.39     -
   Canepa John J Director   –       •      –    2016-05-25 4 B $1.46 $25,172 D/D 17,241 17,241 2.39     -
   Kennedy John F Director   –       •      –    2016-05-20 4 B $1.56 $10,139 D/D 6,500 42,224 2.39     -
   Mcnaughton Thomas Chief Financial Officer   •       –      –    2016-05-20 4 B $1.55 $7,775 D/D 5,000 206,128 2.74     -
   Mcgorry James Joseph President and CEO   •       •      –    2016-05-20 4 B $1.56 $15,600 D/D 10,000 81,300 2.81     -
   Robinson Thomas H Director   –       •      –    2016-05-19 4 B $1.36 $24,401 D/D 18,000 18,000 2.39     -
   La Francesca Saverio Chief Medical Officer   •       –      –    2015-12-17 4 B $2.01 $4,817 D/D 2,393 43,998 2.66     -
   La Francesca Saverio Chief Medical Officer   •       –      –    2015-12-17 4 S $1.93 $4,615 D/D (2,393) 41,605     -
   La Francesca Saverio Chief Medical Officer   •       –      –    2015-12-01 4 B $3.01 $30,052 D/D 10,000 43,998 2.74     -
   Kennedy John F Director   –       •      –    2015-12-01 4 B $2.95 $26,525 D/D 9,000 35,724 2.39     -
   Mcnaughton Thomas Chief Financial Officer   •       –      –    2015-11-19 4 B $1.70 $17,000 D/D 10,000 201,128 2.74     -
   Mcgorry James Joseph President and CEO   •       •      –    2015-11-19 4 B $1.79 $17,900 D/D 10,000 71,300 2.81     -
   Mcnaughton Thomas Chief Financial Officer   •       –      –    2015-11-18 4 B $1.56 $15,600 D/D 10,000 191,128 2.74     -
   Mcnaughton Thomas Chief Financial Officer   •       –      –    2015-11-17 4 B $1.32 $19,800 D/D 15,000 181,128 2.74     -
   Green David Director   –       •      –    2015-11-17 4 B $1.34 $33,500 D/D 25,000 313,259 2.39     -
   La Francesca Saverio Chief Medical Officer   •       –      –    2015-09-18 4 B $1.28 $12,210 D/D 9,500 33,998 2.74     -
  100 Records found
  1  2  3  4   
  Page 3 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us